CORD-19:775b90287b44353bee979abb0970a4666022f86d / 33729-33828 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"Achieved 1:1 vial dosing for \u003e 12 months and had repeated skin testing prior to IT discontinuation.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T351","span":{"begin":0,"end":99},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T351","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T351","span":{"begin":0,"end":99},"obj":"Sentence"}],"attributes":[{"subj":"T351","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T67","span":{"begin":58,"end":62},"obj":"Body_part"}],"attributes":[{"id":"A67","pred":"uberon_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/UBERON_0000014"},{"subj":"T67","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec9395","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93afec"},{"id":"CORD-19-PD-UBERON","color":"#c9ec93"}]}]}}